What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 7 minute read Healthcare Industry News Can Freenome’s $1.1bn SPAC deal unlock a new chapter for blood-based multi-cancer detection? Freenome merges with PCSC in $1.1B deal to go public as FRNM. Find out how its AI-powered blood tests could change early cancer detection. bySrinathDecember 7, 2025